DUBLIN--(BUSINESS WIRE)--
Research and Markets (http://www.researchandmarkets.com/research/9zfhfp/nanomedicine_vol) has announced the addition of Elsevier Science and Technology's new book "Nanomedicine, Vol 508. Cancer, Diabetes, and Cardiovascular, Central Nervous System, Pulmonary and Inflammatory Diseases" to their offering.
This volume in the Methods in Enzymology series comprehensively covers Cancer, Cardiovascular and the central nervous system of Nanomedicine. With an international board of authors, this volume is split into sections that cover subjects such as Diabetes and nanotechnology as potential therapy, Nanomedicines for inflammatory diseases, and Development and use of ceramide nanoliposomes in cancer.
Comprehensively covers Cancer, Cardiovascular and the central nervous system of Nanomedicine. An international board of authors. Split into sections that cover subjects such as Diabetes and nanotechnology as potential therapy, Nanomedicines for inflammatory diseases, and Development and use of ceramide nanoliposomes in cancer.
Key Topics Covered:
- Preparation, characterization, and cellular associations of silicon logic-embedded vectors
- Post-formulation peptide drug loading of nanostructures
- Application of mesoporous silica nanoparticles in intracellular drug delivery
- Multifunctional anticancer nanomedicine based on a magnetically responsive cyanoacrylate polymer
- Development and Use of Ceramide Nanoliposomes in Cancer
Originally posted here:
Research and Markets: Nanomedicine, Vol 508. Cancer, Diabetes, and Cardiovascular, Central Nervous System, Pulmonary ...